Siegfried Segaert

Definition of treatment goals for moderate to severe psoriasis: a European consensus

Ulrich Mrowietz, Knud Kragballe, Kristian Reich et al. · Archives of Dermatological Research · 2010 · 886 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14

Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors

Siegfried Segaert, Eric Van Cutsem · Annals of Oncology · 2005 · 574 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +16

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

Herma H. Fidder, Fabian Schnitzler, Marc Ferrante et al. · Gut · 2008 · 448 citations

Veterinary Medicine, Immunology, Pharmacotherapy +11

Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

J. Bernier, James A. Bonner, Jan B. Vermorken et al. · Annals of Oncology · 2007 · 218 citations · Full text

Medicine, Dermatology, Oncology +16

Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension

P.C.M. van de Kerkhof, Siegfried Segaert, M. Lahfa et al. · British Journal of Dermatology · 2008 · 177 citations

Medicine, Pharmacology, Pharmacotherapy +13